You're reading the free version. Trader adds the live tape and alerts.
Start tracking
TRVI Sale Disclosure
Heffernan Michael Thomas · SEC Form 4 · Filed Sep 17, 2026
Sale
Calculated transaction value
$276.46K
Heffernan Michael Thomas Director
TRVI
Trevi Therapeutics
TRVI
Transaction date
Sep 15, 2026
Public filing date
Sep 17, 2026
Filing lag
Filed 2 days later
TRVI daily price context
Close on/before transaction
$15.04
Sep 15, 2026
First close after public filing
$14.95
Sep 18, 2026
30-day return after filing
-20.4%
Through Oct 19, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 18,321 shares @ $15.09
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001193125-26-394456
Filing cohort
Transactions in this filing
Showing 8 of 8
Trades
8
Issuers
1
Estimated value
$721.91K
Buys / sales
0 / 4
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Trevi Therapeutics, Inc. TRVI | Exercise | Sep 15, 2026 | $56K |
| Trevi Therapeutics, Inc. TRVI Current | Sale | Sep 15, 2026 | $276.46K |
| Trevi Therapeutics, Inc. TRVI | Sale | Sep 15, 2026 | $1.59K |
| Trevi Therapeutics, Inc. TRVI | Sale | Sep 15, 2026 | $316.17K |
| Trevi Therapeutics, Inc. TRVI | Sale | Sep 15, 2026 | $1.59K |
| Trevi Therapeutics, Inc. TRVI | Exercise | Sep 15, 2026 | $0 |
| Trevi Therapeutics, Inc. TRVI | Exercise | Sep 15, 2026 | $0 |
| Trevi Therapeutics, Inc. TRVI | Exercise | Sep 15, 2026 | $70.1K |